Anti-proliferative activity of Bupleurum scrozonerifolium in A549 human lung cancer cells in vitro and in vivo

Cancer Letters

Volumn 222, Issue 2, 2005, Pages 183-193

  Cheng, Yeung Leung ^a   Lee, Shih Chun ^a   Lin, Shinn Zong ^b   Chang, Wen Liang ^c   Chen, Yi Lin ^b   Tsai, Nu Man ^b   Liu, Yao Chi ^a   Tzao, Ching ^a   Yu, Dah Shyong ^a   Harn, Horng Jyh ^b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Apoptosis; Bupleurum scorzonerifolium; Caspases; Cell cycle; Lung cancer; Tubulin

Indexed keywords

ACETONE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BUPLEURUM ROOT; CASPASE 3; CASPASE 9; CASPASE INHIBITOR; PACLITAXEL; TUBULIN; VINBLASTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BUPLEURUM; BUPLEURUM SCROZONERIFOLIUM; CANCER CELL; CANCER INHIBITION; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVATION; EXAMINATION; FEMALE; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MEDICINAL PLANT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN POLYMERIZATION; XENOGRAFT;

BUPLEURUM; BUPLEURUM SCORZONERIFOLIUM;

EID: 18044382891     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.10.015     Document Type: Article

References (31)

1. G. Schwartsmann, M.J. Ratain, G.M. Cragg, J.E. Wong, N. Saijo, and D.R. Parkinson Anticancer drug discovery and development throughout the world J. Clin. Oncol. 20 2002 47S 59S
2. M. Bonham, H. Arnold, B. Montgomery, and P.S. Nelson Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma Cancer Res. 62 2002 3920 3924
3. H. Hu, N.S. Ahn, X. Yang, Y.S. Lee, and K.S. Kang Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell Int. J. Cancer 102 2002 250 253
4. S.T. Kao, C.C. Yeh, C.C. Hsieh, M.D. Yang, M.R. Lee, and H.S. Liu The Chinese medicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell lines by inducing apoptosis via G0/G1 arrest Life Sci. 69 2001 1485 1496
5. A. Vickers Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials Cancer Invest. 20 2002 1069 1079
6. H. Yano, A. Mizoguchi, K. Fukuda, M. Haramaki, S. Ogasawara, and S. Momosaki The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase Cancer Res. 54 1994 448 454
7. X.K. Li, M. Motwani, W. Tong, W. Bornmann, and G.K. Schwartz Huanglian, a chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells Mol. Pharmacol. 58 2000 1287 1293
8. S.M. Lee, M.L. Li, Y.C. Tse, S.C. Leung, M.M. Lee, and S.K. Tsui Paeoniae Radix, a Chinese herbal extract, inhibit hepatoma cells growth by inducing apoptosis in a p53 independent pathway Life Sci. 71 2002 2267 2277
9. D. Bensky, and A. Gamble Chinese herbal Medicine Materia Medica 1993
10. Y.L. Cheng, W.L. Chang, S.C. Lee, Y.G. Liu, H.C. Lin, and C.J. Chen Acetone extract of Bupleurum scorzonerifolium inhibits proliferation of A549 human lung cancer cells via inducing apoptosis and suppressing telomerase activity Life Sci. 73 2003 2383 2394
11. D.S. Yu, C.P. Ma, and S.Y. Chang Establishment and characterization of renal cell carcinoma cell lines with multidrug resistance Urol. Res. 28 2000 86 92
12. M. van Engeland, F.C. Ramaekers, B. Schutte, and C.P. Reutelingsperger A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture Cytometry 24 1996 131 139
13. J.T. Yoon, A.F. Palazzo, D. Xiao, T.M. Delohery, P.E. Warburton, and J.N. Bruce CP248, a derivative of exisulind, causes growth inhibition, mitotic arrest, and abnormalities in microtubule polymerization in glioma cells Mol. Cancer Ther. 1 2002 393 404
14. P. Giannakakou, R. Gussio, E. Nogales, K.H. Downing, D. Zaharevitz, and B. Bollbuck A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells Proc. Natl Acad. Sci. USA 97 2000 2904 2909
15. G. Pratesi, M. de Cesare, N. Carenini, P. Perego, S.C. Righetti, and C. Cucco Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts Clin. Cancer Res. 8 2002 3904 3909
16. T. Yamori, A. Matsunaga, S. Sato, K. Yamazaki, A. Komi, and K. Ishizu Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel Cancer Res. 59 1999 4042 4049
17. O. Tounekti, J. Belehradek Jr., and L.M. Mir Relationships between DNA fragmentation, chromatin condensation, and changes in flow cytometry profiles detected during apoptosis Exp. Cell Res. 217 1995 506 516
18. V.L. Johnson, S.C. Ko, T.H. Holmstrom, J.E. Eriksson, and S.C. Chow Effector caspases are dispensable for the early nuclear morphological changes during chemical-induced apoptosis J. Cell Sci. 113 Pt 17 2000 2941 2953
19. M. van Engeland, L.J. Nieland, F.C. Ramaekers, B. Schutte, and C.P. Reutelingsperger Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure Cytometry 31 1998 1 9
20. S.J. Martin, and D.R. Green Apoptosis and cancer: the failure of controls on cell death and cell survival Crit Rev. Oncol. Hematol. 18 1995 137 153
21. W. Hu, and J.J. Kavanagh Anticancer therapy targeting the apoptotic pathway Lancet Oncol. 4 2003 721 729
22. S.J. Martin, C.P. Reutelingsperger, A.J. McGahon, J.A. Rader, R.C. van Schie, and D.M. LaFace Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl J. Exp. Med. 182 1995 1545 1556
23. D.W. Nicholson, and N.A. Thornberry Caspases: killer proteases Trends Biochem. Sci. 22 1997 299 306
24. G.S. Salvesen, and V.M. Dixit Caspases: intracellular signaling by proteolysis Cell 91 1997 443 446
25. E.S. Alnemri, D.J. Livingston, D.W. Nicholson, G. Salvesen, N.A. Thornberry, W.W. Wong, and J. Yuan Human ICE/CED-3 protease nomenclature Cell 87 1996 171
26. A. Carnero Targeting the cell cycle for cancer therapy Br. J. Cancer 87 2002 129 133
27. P. Giannakakou, D. Sackett, and T. Fojo Tubulin/microtubules: still a promising target for new chemotherapeutic agents J. Natl Cancer Inst. 92 2000 182 183
28. L. Tan, Y. Zhao, G. Tu, B. Wang, S. Cai, and R. Zhang Saikosaponins from roots of Bupleurum scorzonerifolium Phytochemistry 50 1999 139 142
29. B.P. Bermejo, M.J. Abad Martinez, A.M. Silvan Sen, G.A. Sanz, M.L. Fernandez, C.S. Sanchez, and A.M. Diaz Lanza In vivo and in vitro antiinflammatory activity of saikosaponins Life Sci. 63 1998 1147 1156
30. P. Bermejo, M.J. Abad, A.M. Diaz, L. Fernandez, J.D. Santos, and S. Sanchez Antiviral activity of seven iridoids, three saikosaponins and one phenylpropanoid glycoside extracted from Bupleurum rigidum and Scrophularia scorodonia Planta Med. 68 2002 106 110
31. I.S. Park, E.M. Kang, and N. Kim High-performance liquid chromatographic analysis of saponin compounds in Bupleurum falcatum J. Chromatogr. Sci. 38 2000 229 233